Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Dexrabeprazole

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Novel capillary electrophoresis methods using CDs as chiral selectors were developed and validated for the chiral separation of… Expand
2016
2016
Background and Aims : Aspiration of gastric contents in the lungs is one of the most feared complications of anaesthesia… Expand
2014
2014
Enantioresolution of four anti-ulcer drugs (chiral sulfoxides), namely, omeprazole, rabeprazole, lansoprazole and pantoprazole… Expand
2014
2014
Dexrabeprazole is a novel proton pump inhibitor that is used in the treatment of Gastro oesophageal reflux disease. This report… Expand
  • table 2
2010
2010
A stability-indicating thin layer chromatographic (TLC) method for determination of dexrabeprazole (DEX) and domperidone (DOM) in… Expand
2010
2010
A validated reverse phase high performance liquid c hromatography method has been developed for the simultaneous determination of… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
2009
2009
Abstract Dexrabeprazole [R(+) rabeprazole] is a novel proton-pump inhibitor which has recently become available in India for the… Expand
2008
2008
Ten mg dexrabeprazole daily has been shown to be more effective than 20 mg rabeprazole daily against gastroesophageal reflux… Expand
2007
2007
AIM To compare the efficacy and safety of dexrabeprazole 10 mg versus rabeprazole 20 mg in the treatment of gastroesophageal… Expand
2006
2006
All currently available proton pump inhibitors (PPI) are substituted benzimidazole pro-drugs and chiral compounds. Rabeprazole is… Expand
  • table 1